Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

European Commission authorises first-ever rare blood condition drug

September 4, 2018 Manufacturing and Production, Sales and Marketing Europe, Sanofi, approvals, cablivi, eu commission

Sanofi have announced that the European Commission granted marketing authorisation for Cablivi (caplacizumab) for the treatment of adults experiencing an …
News
janssen_latest_logo_on_sign

Europe approves Janssen’s Darzalex in frontline multiple myeloma

September 4, 2018 Manufacturing and Production, Research and Development, Sales and Marketing EU, Europe, J&J, JJ, Janssen, darzalex, multiple myeloma, pharma

Janssen has revealed that its CD38-targeting biologic drug Darzalex (daratumumab) has received approval from the European Commission, authorising its use …
News

Faubel-Booklet Labels

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Faubel-Booklet Labels with temperature indicators from ELPRO identify and monitor pharmaceutical products Melsungen, 3rd of September 2018Pharmaceutical products without proper …
News
Press release
shutterstock_192094955_web

Widening the focus on innovations in cancer treatment

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …
Feature
5204602349_c87b204860_z

FDA rejects Sunovion’s ADHD drug dasotraline

September 3, 2018 Sales and Marketing ADHD, FDA, dasotraline, drug, sunovion

The US Food and Drug Administration (FDA) have rejected American pharma firm Sunovion’s application to market dasotraline for the treatment …
News
450px-academisch_medisch_centrum_amsterdam_001

Dutch doctors resist pharma firm’s 500-fold price hike

September 3, 2018 Sales and Marketing Netherlands, leadiant, pharma, pricing

A group of Dutch doctors and health advocates are taking action against the Italian pharmaceutical firm Leadiant Biosciences who have …
News
pharmafocus_oct_2018

The September 2018 issue of Pharmafocus is available to read online now!

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
News

AI used to forecast cancer progression

September 3, 2018 Sales and Marketing AI, Cancer, ICR, London, ai drug research and development, university of edinburgh

A team of scientists at the Institute of Cancer Research (ICR) in London and the University of Edinburgh have developed …
News
28246711066_52e38bc591_z

MHRA loses EMA contracts in wake of Brexit

September 3, 2018 Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation

The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten

Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
News

DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
News
Press release
shire_image

Shire hands over its oncology franchise to Servier for $2.4bn

August 31, 2018 Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
News

Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer

August 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon

Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …
Appointment
credit_natural_cycles

Contraceptive app Natural Cycles investigated over “misleading” efficacy claims

August 30, 2018 Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma

The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …
News
astrazeneca_building_white

AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes

August 30, 2018 Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes

AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025